Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older PatientsYang Mao‐Draayer, Fabrizio Giuliani, Kyle Smoot et al.|Advances in Therapy|2024Cited by 6
Immunomodulatory Effects of DMF Treatment on the Peripheral Lymphocyte Compartment: A Focus on Older MS Patients (478)Fabrizio Giuliani, Catherine Miller, Erin E. Longbrake et al.|Neurology|2020Cited by 1